into the vasculature; carotid shunts to temporarily divert blood to the brain during the removal of plaque from the carotid artery; and laparoscopic cholecystectomy devices to inject dye into the cystic duct during laparoscopic cholecystectomy. The company also offers manual contrast injectors for the injection of contrast media into blood vessels; modeling catheters to apply radial pressure to the inside of an aortic stent graft for sealing; radiopaque tape to improve the precision of vascular and endovascular procedures; and remote endarterectomy devices to remove severe atherosclerotic blockages from the arteries of the leg. In addition, it provides valvulotomes for use as a bypass vessel to carry blood past diseased arteries to the lower leg or the foot; vascular grafts to bypass or replace diseased arteries; vascular patches that are synthetic and biological patches for use in closing incisions in a blood vessel; vein strippers for single-incision removal of varicose veins; and vessel closure systems to attach blood vessels for dialysis access. LeMaitre Vascular, Inc. markets its products through direct and indirect sales force, and distributors.